Why the study?
Does cardiac resynchronization therapy reduce mortality in patients with heart failure?
Does cardiac resynchronization therapy reduce mortality in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Cardiac resynchronization therapy provides a conclusive mortality benefit for patients with heart failure when added to standard medical or defibrillator therapies.
The cumulative evidence is now conclusive that the addition of cardiac resynchronization to optimal medical therapy or defibrillator therapy significantly reduces mortality among patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Wells et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: